These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8294881)

  • 41. Role of glucocorticoid in the upregulation of type I interleukin-1 receptor mRNA expression in hepatocytes of endotoxin-administrated mice.
    Ito A; Takii T; Goto N; Kito Y; Onozaki K
    J Interferon Cytokine Res; 1997 Jul; 17(7):413-7. PubMed ID: 9243374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokines and dexamethasone modulation of IL-1 receptors on human neutrophils in vitro.
    Shieh JH; Peterson RH; Moore MA
    J Immunol; 1993 Apr; 150(8 Pt 1):3515-24. PubMed ID: 8468485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and biological properties of an interleukin-1 receptor immunoadhesin.
    Pitti RM; Marsters SA; Haak-Frendscho M; Osaka GC; Mordenti J; Chamow SM; Ashkenazi A
    Mol Immunol; 1994 Dec; 31(17):1345-51. PubMed ID: 7997246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity.
    McKean DJ; Podzorski RP; Bell MP; Nilson AE; Huntoon CJ; Slack J; Dower SK; Sims J
    J Immunol; 1993 Oct; 151(7):3500-10. PubMed ID: 8376789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-related inhibition of proinflammatory cytokine release from neutrophils of the newborn by dexamethasone, betamethasone, and hydrocortisone.
    Irakam A; Miskolci V; Vancurova I; Davidson D
    Biol Neonate; 2002 Aug; 82(2):89-95. PubMed ID: 12169830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro and in vivo study of regulation mechanisms of type I interleukin-1 receptor].
    Takii T
    Yakugaku Zasshi; 2001 Jan; 121(1):9-21. PubMed ID: 11201166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selectivity release of the type II decoy IL-1 receptor.
    Orlando S; Polentarutti N; Mantovani A
    Cytokine; 2000 Jul; 12(7):1001-6. PubMed ID: 10880245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Type I IL-1 receptor: ligand specific confirmation differences and the role of glycosylation in ligand binding.
    Einstein R; Jackson JR; D'Alessio K; Lillquist JS; Sathe G; Porter T; Young PR
    Cytokine; 1996 Mar; 8(3):206-13. PubMed ID: 8833035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor.
    Sadouk MB; Pelletier JP; Tardif G; Kiansa K; Cloutier JM; Martel-Pelletier J
    Lab Invest; 1995 Sep; 73(3):347-55. PubMed ID: 7564267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes.
    Dickensheets HL; Donnelly RP
    J Immunol; 1997 Dec; 159(12):6226-33. PubMed ID: 9550426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.
    Petroni KC; Shen L; Guyre PM
    J Immunol; 1988 May; 140(10):3467-72. PubMed ID: 2966197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection and in vivo hormonal regulation of rat ovarian type I and type II interleukin-I receptor mRNAs: increased expression during the periovulatory period.
    Scherzer WJ; Ruutiainen-Altman KS; Putowski LT; Kol S; Adashi EY; Rohan RM
    J Soc Gynecol Investig; 1996; 3(3):131-9. PubMed ID: 8796821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
    Lee SA; Fitzgerald SM; Huang SK; Li C; Chi DS; Milhorn DM; Krishnaswamy G
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):283-91. PubMed ID: 15191916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
    Levine SJ; Wu T; Shelhamer JH
    J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-1 beta primes interleukin-8-stimulated chemotaxis and elastase release in human neutrophils via its type I receptor.
    Brandolini L; Sergi R; Caselli G; Boraschi D; Locati M; Sozzani S; Bertini R
    Eur Cytokine Netw; 1997 Jun; 8(2):173-8. PubMed ID: 9262966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M; Richards CD; Gauldie J
    Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of soluble type II receptor in the presence of its natural ligand IL-1 beta. Quantification by sandwich ELISA.
    Altenberger EA; Pope HA; Wewers MD
    J Immunol Methods; 1995 Sep; 185(1):115-22. PubMed ID: 7665893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-1 down-regulates type I interleukin 1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E2 synthesis.
    Takii T; Hayashi H; Marunouchi T; Onozaki K
    Lymphokine Cytokine Res; 1994 Jun; 13(3):213-9. PubMed ID: 7948430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dexamethasone and cyclosporin A modulation of human retinal pigment epithelial cell monocyte chemotactic protein-1 and interleukin-8.
    Kurtz RM; Elner VM; Bian ZM; Strieter RM; Kunkel SL; Elner SG
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):436-45. PubMed ID: 9040477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts.
    Penton-Rol G; Orlando S; Polentarutti N; Bernasconi S; Muzio M; Introna M; Mantovani A
    J Immunol; 1999 Mar; 162(5):2931-8. PubMed ID: 10072543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.